Expert Review of Clinical Pharmacology

Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson''s disease
pp. 1-4(4)
Authors: Postma, Maarten J; Boersma, Cornelis

Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach
pp. 5-8(4)
Authors: van den Anker, John; Allegaert, Karel

Macrocyclic antibiotics: a novel class of drug for the treatment of Clostridium difficile infection
pp. 9-11(3)
Author: Blondeau, Joseph M

News in brief
pp. 13-15(3)

Insulin to treat Alzheimer''s disease: just follow your nose?
pp. 17-20(4)
Authors: Schiöth, Helgi B; Frey, William H; Brooks, Samantha J; Benedict, Christian

Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis
pp. 21-30(10)
Author: Jung-Cook, Helgi

Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review
pp. 31-42(12)
Authors: Freeman, Jeffrey S; Gross, Benjamin

Is combination therapy an effective way of reaching lipid goals in Type 2 diabetes mellitus?
pp. 43-54(12)
Authors: Handelsman, Yehuda; Fonseca, Vivian; Rosenstock, Julio

Diabetic macular edema: new trends in management
pp. 55-68(14)
Authors: Shamsi, Hanan Al; Ghazi, Nicola G

Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response
pp. 69-89(21)
Authors: Cressman, Alexander M; Petrovic, Vanja; Piquette-Miller, Micheline

Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials
pp. 91-97(7)
Authors: Ang-Tiu, Charlene U; Meghrajani, Chandra F; Maano, Clarita C

Acknowledgements
pp. 99-99(1)